Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management

Lignende værker

• Neoadjuvant Radiation Therapy Prior to Total Mesorectal Excision for Rectal Cancer is Not Associated with Postoperative Complications Using Current Techniques
  af: Milgrom, Sarah A., et al.
  Udgivet: (2014)
• Effect of Neoadjuvant Systemic Chemotherapy with or without Chemoradiation on Bowel Function in Rectal Cancer Patients Treated with Total Mesorectal Excision
  af: Quezada-Diaz, Felipe, et al.
  Udgivet: (2018)
• Neoadjuvant Chemotherapy First, Followed by Chemoradiation and Then Surgery, in the Management of Locally Advanced Rectal Cancer
  af: Cercek, Andrea, et al.
  Udgivet: (2014)
• Local Excision After Preoperative Chemoradiation Results in an Equivalent Outcome to Total Mesorectal Excision in Selected Patients with T3 Rectal Cancer
  af: Callender, Glenda G., et al.
  Udgivet: (2009)
• Total mesorectal excision for the treatment of rectal cancer
  af: Zedan, Ali, et al.
  Udgivet: (2015)